What's in a name? Why words matter in advanced prostate cancer Editorial

  

Authors:	Oh, W. K.; Agarwal, N.; Bryce, A.; Barata, P.; Bugler, C.; Carlsson, S. V.; Cornell, B.; Dahut, W.; George, D.; Loeb, S.; Montgomery, B.; Morris, D.; Mucci, L. A.; Omlin, A.; Palapattu, G.; Riaz, I. B.; Ryan, C.; Schoen, M. W.; Washington, S. L. 3rd; Gillessen, S.
Title:	What's in a name? Why words matter in advanced prostate cancer
Keywords:	overall survival; advanced cancer; quality of life; editorial; docetaxel; prostate cancer; confusion; comorbidity; nomenclature; abiraterone acetate; bone marrow transplantation; metastatic prostate cancer; life sustaining treatment; enzalutamide; human; apalutamide; metastatic castration sensitive prostate cancer; darolutamide; castration sensitive prostate cancer; person centered care; androgen deprivation resistant prostate cancer
Journal Title:	European Urology
Volume:	87
Issue:	2
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2025-02-01
Start Page:	101
End Page:	103
Language:	English
DOI:	10.1016/j.eururo.2024.10.017
PUBMED:	39472202
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85207802889&doi=10.1016%2fj.eururo.2024.10.017&partnerID=40&md5=b8e97edc0ac03864a90a0729b5d15416
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222336